Lamotrigine treatment of a patient affected by epilepsy and anxiety disorder

Psychiatria Danubina

Volumn 23, Issue 1, 2011, Pages 111-113

  Šepić Grahovac, Dubravka ^a   Grahovac, Tanja ^b   Ružić Baršić, Antonija ^b   Ružić, Klementina ^b   Dadić Hero, Elizabeta ^c  

^a Policlinic for Neurology and Psychiatry Interneuron   (Croatia)

^b KBC RIJEKA   (Croatia)

^c UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Anxiety disorders; Epilepsy; Lamotrigine

Indexed keywords

ALPRAZOLAM; LAMOTRIGINE; SULPIRIDE;

ADULT; ANXIETY DISORDER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ELECTROENCEPHALOGRAM; EPILEPSY; FATIGUE; HUMAN; HYPERVENTILATION; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PALEA; PERCEPTION DISORDER; PHOTOSTIMULATION; PSYCHOTHERAPY; RESTLESSNESS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX; WALKING;

ADULT; ANTICONVULSANTS; ANXIETY DISORDERS; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY, COMPLEX PARTIAL; EPILEPSY, POST-TRAUMATIC; FOLLOW-UP STUDIES; HUMANS; MALE; TRIAZINES;

EID: 79953814846     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E & Rudd GD. A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry. 1999; 60:79-88. (Pubitemid 29104383)
2. Charyton C, Elliott JO, Lu B & Moore JL. The impact of social support on health related quality of life in persons with epilepsy. Epilepsy and Behav. 2009; 16:640-645.
3. Droge D, Arntson P & Norton R. The social support Junction in epilepsy self-help groups. Small Group Res. 1986; 17:139-63.
4. Elliott JO, Moore JL & Lu B. Health status and behavioral risk factors among persons With epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System. Epilepsy Behav. 2008; 12:434-444.
5. Fatemi SH, Rappoport DJ, Calabrese JR & Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry. 1997; 58:522-527. (Pubitemid 28100271)
6. Fitton A & Goa KI. Lamotrigine. Drugs, 1995; 50:691-713.
7. Hills MD & Baker PG. Relationships among epilepsy, social stigma, self-esteem and social support. J Epilepsy. 1992; 5:231-238.
8. Jacoby A & Baker GA. Quality of life trajectories in epilepsy: a review of the literature. Epilepsy Behav. 2008; 12:557-571.
9. Kanner AM, Kozak AM & Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 2000; 1:100-105.
10. Kanner AM & Nieto JC. Depressive disorders in epilepsy. Neurology 1999; 53: 26-32.
11. Kanner AM & Palac S. Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav. 2000; 1:37-51.
12. Resinger EL & Dilorio C. Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months. Epilepsy Behav. 2009; 15:196-201.
13. Smith DB, Craft BR, Collins J, Mattson RH & Cramer JA. Behavioural characteristics of epilepsy patients with normal controls. Epilepsia. 1986; 27:760-768. (Pubitemid 17226919)
14. Suurmeijer TP, Reuvekamp MF & Aldenkamp BP. Social functioning, psychological functioning and quality of life in epilepsy. Epilepsia. 2001; 42:1160-1168. (Pubitemid 32947937)